News

For Immediate Release

Chicago, IL – May 14, 2024 – Stocks in this week’s article are Medpace Holdings, Inc. MEDP, American Axle & Manufacturing Holdings, Inc. AXL, Diebold Nixdorf, Inc. DBD, Euronet Worldwide, Inc. EEFT and Omnicom Group Inc. OMC.

5 Stocks with Upgraded Broker Ratings Worth Investing In Now

Given low consumer confidence and weakness in the labor market, the markets are predicting rate cuts sooner than previously expected. The Federal Reserve officials, though, are still maintaining their stance that rates will remain high for a longer period. Amid such a macroeconomic backdrop, it becomes difficult to choose stocks independently and generate robust returns.

For this, one has to understand the fundamentals of a company and try to place them against the present economic background to figure out how it may fare as an investment. One way to cut short this task is to follow brokers’ recommendations.

Hence, stocks like Medpace Holdings, Inc., American Axle & Manufacturing Holdings, Inc., Diebold Nixdorf, Inc., Euronet Worldwide, Inc. and Omnicom Group Inc. are worth considering.

As brokers directly communicate with the top management, they have a deeper insight into what is happening in a particular company. They assess companies’ publicly available documents and even attend conference calls.

Brokers have more understanding of the overall sector and industry. They place company fundamentals against the current economic backdrop to determine how a particular stock will fare as an investment.

When brokers upgrade a stock, one can easily rely on their judgment. However, depending on broker upgrades is not the correct way to build your investment portfolio. Several other factors should be taken into account to ensure steady returns.

Here are five of the 20 stocks that qualified for the screening:

Headquartered in Cincinnati, OH, Medpace provides clinical research-based drug and medical device development services. MEDP offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas.

Medpace’s earnings estimates for 2024 have been revised 6.6% north over the past 30 days. MSDP, sporting a Zacks Rank #1, has witnessed a 16.7% upward revision in broker ratings over the past four weeks.

Headquartered in Detroit, MI, American Axle & Manufacturing is a leading supplier of driveline and drivetrain systems, modules and components for the light vehicle market. AXL manufactures Driveline and Metal Forming technologies to support electric, hybrid and internal combustion vehicles.

American Axle & Manufacturing’s 2024 earnings estimates have been revised 26.7% upward over the past 30 days. AXL, carrying a Zacks Rank #2 at present, has witnessed a 12.5% upward revision in broker ratings over the past four weeks.

Diebold Nixdorf, based in North Canton, OH, is engaged in automating, digitizing and transforming the way people bank and shop worldwide. DBD operates through two segments - Banking and Retail.

Diebold Nixdorf’s 2024 earnings estimates have jumped 47% upward over the past 30 days. DBD, sporting a Zacks Rank #1 at present, has witnessed a 50% upward revision in broker ratings in the past four weeks.

Headquartered in Leawood, KS, Euronet is a leading electronics payments provider. EEFT offers payment and transaction processing and distribution solutions to financial institutions, retailers, consumers and service providers.

Euronet’s 2024 earnings estimates have been revised 2% upward over the past month. EEFT, carrying a Zacks Rank #2 at present, has witnessed an 11.1% upward revision in broker ratings over the past four weeks.

Omnicom, based in New York, is one of the largest advertising, marketing and corporate communications companies in the world. OMC’s agencies operate in all the major markets across the globe and provide an extensive range of services.

Omnicom’s 2024 earnings estimates have been revised 1.4% upward over the past 30 days. OMC, carrying a Zacks Rank #2 at present, has witnessed an 18.2% upward revision in broker ratings over the past four weeks.

Get the rest of the stocks on the list and start putting this and other ideas to the test. It can all be done with the Research Wizard stock picking and backtesting software.

The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out.

Click here to sign up for a free trial of the Research Wizard today.

For the rest of this Screen of the Week article please visit Zacks.com at: https://www.zacks.com/stock/news/2272604/5-stocks-with-upgraded-broker-ratings-worth-investing-in-now

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Contact: Jim Giaquinto

Company: Zacks.com

Phone: 312-265-9268

Visit: https://www.zacks.com/

Zacks.com provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. www.zacks.com/disclaimer.

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.

Research Chief Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

This company targets millennial and Gen Z audiences, generating nearly $1 billion in revenue last quarter alone. A recent pullback makes now an ideal time to jump aboard. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.

Free: See Our Top Stock And 4 Runners Up

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.